BlackRock Group’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $589K | Buy |
142,479
+49,821
| +54% | +$206K | ﹤0.01% | 2293 |
|
|
2016
Q3 | $750K | Buy |
92,658
+44,678
| +93% | +$362K | ﹤0.01% | 2148 |
|
|
2016
Q2 | $374K | Buy |
47,980
+1,045
| +2% | +$8.15K | ﹤0.01% | 2353 |
|
|
2016
Q1 | $363K | Buy |
46,935
+14,220
| +43% | +$110K | ﹤0.01% | 2346 |
|
|
2015
Q4 | $352K | Sell |
32,715
-747
| -2% | -$8.04K | ﹤0.01% | 2324 |
|
|
2015
Q3 | $231K | Buy |
33,462
+4,550
| +16% | +$31.4K | ﹤0.01% | 2476 |
|
|
2015
Q2 | $256K | Buy |
28,912
+8,679
| +43% | +$76.8K | ﹤0.01% | 2498 |
|
|
2015
Q1 | $200K | Buy |
20,233
+10,308
| +104% | +$102K | ﹤0.01% | 2487 |
|
|
2014
Q4 | $121K | Sell |
9,925
-3,636
| -27% | -$44.3K | ﹤0.01% | 2630 |
|
|
2014
Q3 | $136K | Buy |
13,561
+12,300
| +975% | +$123K | ﹤0.01% | 2523 |
|
|
2014
Q2 | $10K | Hold |
1,261
| – | – | ﹤0.01% | 2767 |
|
|
2014
Q1 | $4K | Hold |
1,261
| – | – | ﹤0.01% | 2708 |
|
|
2013
Q4 | $4K | Hold |
1,261
| – | – | ﹤0.01% | 2630 |
|
|
2013
Q3 | $4K | Hold |
1,261
| – | – | ﹤0.01% | 2863 |
|
|
2013
Q2 | $10K | Buy |
+1,261
| New | +$10K | ﹤0.01% | 2544 |
|